4 Lipid Late-breaker Highlights from ACC.22 with Dr Erin Michos

Published: 14 Apr 2022

  • Views:

    Views Icon 693
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

What are the lipid highlights from ACC.22?

In this insightful review, Dr Erin Michos (Johns Hopkins University School of Medicine, Baltimore, MD, US) talks about selected ACC.22 late-breaking clinical trials highlighting the take-home messages for clinical practice. 

Trials covered in detail include:
00:28: APOLLO Trial: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial
01:56: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial
3:29: TRANSLATE-TIMI 70: Effect of Vupanorsen on Non-high-density Lipoprotein Cholesterol Levels In Statin-treated Patients With Elevated Cholesterol
05:05: SuperWIN: A Multisite, Randomized, Controlled Trial of a Supermarket and Web-based Intervention Targeting Nutrition For Cardiovascular Risk Reduction

Recorded on-site at ACC.22, Washington DC.

Videography:Dan Brent, Tom Green